Clinical Trial Update: Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Fespixon Cream for diabetic foot ulcers (TEXAS 3A/3B) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Fespixon Cream

Snippet

Sponsor: Oneness Biotech Co., Ltd. | Conditions: Diabetic Foot Ulcer (DFU) | Phase 4 | Status: TERMINATED